SCHEMBL21136770

SCHEMBL21136770

CNc1cnc2c(F)c(-c3c(O)cccc3F)c(F)cc2c1N1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KRAS P01116 5/20 0.41
EGFR P00533 1/20 0.41
HMOX2 P30519 1/20 0.41
CRYZ Q08257 1/20 0.41
VAT1 Q99536 1/20 0.41
RTN4 Q9NQC3 1/20 0.41
KIT P10721 2/20 0.39
SMARCA2 P51531 1/20 0.39
SMARCA4 P51532 1/20 0.39
PBRM1 Q86U86 1/20 0.39
CKS1B P61024 2/20 0.39
SKP1 P63208 2/20 0.39
SKP2 Q13309 2/20 0.39
ALK Q9UM73 2/20 0.39
GPR119 Q8TDV5 4/20 0.37
CXCR2 P25025 1/20 0.37
TP53 P04637 1/20 0.36
THRB P10828 1/20 0.36
BACE1 P56817 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21137337 0.83 CXCR2 (0.41) KRASEGFRHMOX2CRYZVAT1
SCHEMBL21136729 0.83 GPR119 (0.41) KITCKS1BSKP1SKP2ALK
SCHEMBL21136914 0.82 KDM4E (0.40) KRASEGFRHMOX2CRYZVAT1
SCHEMBL21137067 0.82 KRAS (0.51) KRASEGFRHMOX2CRYZVAT1
SCHEMBL21099225 0.77 KRAS (0.68) KRASEGFRHMOX2CRYZVAT1
SCHEMBL21137320 0.74 KRAS (0.43) KRASEGFRHMOX2CRYZVAT1
SCHEMBL16637000 0.72 KRAS (0.44) KRASEGFRHMOX2CRYZVAT1
SCHEMBL18153456 0.71 KRAS (0.47) KRASEGFRHMOX2CRYZVAT1
SCHEMBL21137556 0.71 GPR119 (0.41) KITALKGPR119BACE1
SCHEMBL18128681 0.70 KRAS (0.55) KRASEGFRHMOX2CRYZVAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019110751-A1 TETRACYCLIC COMPOUNDS AS INHIBITORS OF G12C MUTANT RAS PROTEIN, FOR USE AS ANTI-CANCER AGENTS ASTRAZENECA AB (SE) 2019-06-13 WO disclosed